---
document_datetime: 2023-09-21 22:07:19
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rivastigmine-1-pharma-epar-all-authorised-presentations_en.pdf
document_name: rivastigmine-1-pharma-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.9117097
conversion_datetime: 2025-12-19 04:08:41.147009
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EUNumber        | Name                   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging            | Content (concentration)   | Package size   |
|-----------------|------------------------|------------|-----------------------|---------------------------|----------------------|---------------------------|----------------|
| EU/1/09/585/001 | Rivastigmine 1 APharma | 1.5 mg     | Capsule, hard         | Oral use                  | blister (PVC/alu)    |                           | 28             |
| EU/1/09/585/002 | Rivastigmine 1 APharma | 1.5 mg     | Capsule, hard         | Oral use                  | blister (PVC/alu)    |                           | 56             |
| EU/1/09/585/003 | Rivastigmine 1 APharma | 1.5 mg     | Capsule, hard         | Oral use                  | blister (PVC/alu)    |                           | 112            |
| EU/1/09/585/005 | Rivastigmine 1 APharma | 3 mg       | Capsule, hard         | Oral use                  | blister (PVC/alu)    |                           | 28             |
| EU/1/09/585/006 | Rivastigmine 1 APharma | 3 mg       | Capsule, hard         | Oral use                  | blister (PVC/alu)    |                           | 56             |
| EU/1/09/585/007 | Rivastigmine 1 APharma | 3 mg       | Capsule, hard         | Oral use                  | blister (PVC/alu)    |                           | 112            |
| EU/1/09/585/009 | Rivastigmine 1 APharma | 4.5 mg     | Capsule, hard         | Oral use                  | blister (PVC/alu)    |                           | 28             |
| EU/1/09/585/010 | Rivastigmine 1 APharma | 4.5 mg     | Capsule, hard         | Oral use                  | blister (PVC/alu)    |                           | 56             |
| EU/1/09/585/011 | Rivastigmine 1 APharma | 4.5 mg     | Capsule, hard         | Oral use                  | blister (PVC/alu)    |                           | 112            |
| EU/1/09/585/013 | Rivastigmine 1 APharma | 6 mg       | Capsule, hard         | Oral use                  | blister (PVC/alu)    |                           | 28             |
| EU/1/09/585/014 | Rivastigmine 1 APharma | 6 mg       | Capsule, hard         | Oral use                  | blister (PVC/alu)    |                           | 56             |
| EU/1/09/585/015 | Rivastigmine 1 APharma | 6 mg       | Capsule, hard         | Oral use                  | blister (PVC/alu)    |                           | 112            |
| EU/1/09/585/017 | Rivastigmine 1 APharma | 2 mg / ml  | Oral solution         | Oral use                  | bottle (amber glass) | 50 ml                     | 1 bottle       |
| EU/1/09/585/018 | Rivastigmine 1 APharma | 2 mg / ml  | Oral solution         | Oral use                  | bottle (amber glass) | 120 ml                    | 1 bottle       |